Sangamo Therapeutics(GB:0R1D)
$0.110.00 (0.00%)
GB:0R1D
Sangamo Therapeutics ownership
$0.11
At close:0.00 (0.00%)
Sangamo Therapeutics (0R1D) Ownership - Who Owns Sangamo Therapeutics?
0 Followers
Sangamo Therapeutics (0R1D) Ownership Overview
- 0.94% Insiders
- 1.62% Mutual Funds
- 0.10% Other Institutional Investors
- 97.34% Public Companies and Individual Investors
The ownership structure of Sangamo Therapeutics (GB:0R1D) stock is a mix of institutional, retail, and individual investors. Approximately 1.73% of the company’s stock is owned by Institutional Investors, 0.94% is owned by Insiders, and 97.34% is owned by Public Companies and Individual Investors.
The ownership structure of Sangamo Therapeutics (GB:0R1D) stock is a mix of institutional, retail, and individual investors. Approximately 1.73% of the company’s stock is owned by Institutional Investors, 0.94% is owned by Insiders, and 97.34% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Apr 22, 2026 | Nathalie Dubois-stringfellow | $86,486 | |
| Apr 22, 2026 | Gregory D Davis | $17,457 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Graham Capital Management, L.p. | $135,171 | |
| Dec 31, 2025 | Oracle Investment Management Inc | $435,011 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Wasatch Funds Trust | 4,583,334 | Institution | 1.11% | 490,417 |
| BlackRock, Inc. | 4,547,848 | Institution | 1.10% | 486,620 |
| Sandy Macrae | 1,895,043 | Insider | 0.46% | 202,770 |
| Delaware Group Equity Funds Iv | 1,200,000 | Institution | 0.29% | 128,400 |
| Peter Durbin | 1,035,742 | Institution | 0.25% | 110,824 |
| Prathyusha Duraibabu | 660,042 | Insider | 0.16% | 70,624 |
| Tiaa-cref Funds | 657,047 | Institution | 0.16% | 70,304 |
| Scott B. Willoughby | 647,370 | Insider | 0.16% | 69,269 |
| Nathalie Dubois-stringfellow | 328,733 | Insider | 0.08% | 35,174 |
| Kenneth Tropin | 321,837 | Institution | 0.08% | 34,437 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Wasatch Funds Trust | 4,583,334 | Institution | 1.11% | 490,417 |
| Delaware Group Equity Funds Iv | 1,200,000 | Institution | 0.29% | 128,400 |
| Tiaa-cref Funds | 657,047 | Institution | 0.16% | 70,304 |
| Fidelity Commonwealth Trust Ii | 177,187 | Institution | 0.04% | 18,959 |
| Northern Funds | 54,511 | Institution | 0.01% | 5,833 |
| Fidelity Rutland Square Trust Ii | 36,600 | Institution | <0.01% | 3,916 |
| Victory Portfolios Iii | 14,725 | Institution | <0.01% | 1,576 |
FAQ
Who Owns Sangamo Therapeutics (GB:0R1D)?
According to the latest TipRanks data, approximately 1.73% of the company's stock is held by institutional investors, 0.94% is held by insiders, and 97.34% is held by public companies and individual investors.
What percentage of Sangamo Therapeutics (GB:0R1D) stock is held by institutional investors?
According to the latest TipRanks data, approximately 1.73% of Sangamo Therapeutics (GB:0R1D) stock is held by institutional investors: 1.62% by mutual funds and 0.10% by other institutional investors.
What percentage of Sangamo Therapeutics (GB:0R1D) stock is held by retail investors?
According to the latest TipRanks data, approximately 97.34% of Sangamo Therapeutics (GB:0R1D) stock is held by public companies and individual investors.
Who owns the most shares of Sangamo Therapeutics (GB:0R1D)?
WASATCH FUNDS TRUST owns the most shares of Sangamo Therapeutics (GB:0R1D).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
